Testing effectiveness (Phase 2)WithdrawnNCT04243941What this trial is testingPSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerWho this might be right forProstate Cancer UNC Lineberger Comprehensive Cancer Center
Not applicableStudy completedNCT01542021What this trial is testingAndrogen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerWho this might be right forProstate CancerProstatic Adenocarcinoma Memorial Sloan Kettering Cancer Center 41
Not applicableNot Yet RecruitingNCT07210502What this trial is testingSide Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate CancerWho this might be right forProstate Adenocarcinoma Royal Surrey County Hospital NHS Foundation Trust 220
Not applicableActive Not RecruitingNCT02339701What this trial is testingStereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate CancerWho this might be right forProstate Cancer Chinese University of Hong Kong 68
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530What this trial is testingCOACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerWho this might be right forProstate Cancer Brazilian Clinical Research Institute 144
Large-scale testing (Phase 3)UnknownNCT00175396What this trial is testingAndrogen Suppression Combined With Elective Nodal and Dose Escalated Radiation TherapyWho this might be right forProstate Cancer University of British Columbia 400
Not applicableEnded earlyNCT01414712What this trial is testingCirculating Tumor Cells in Prostate Cancer PatientsWho this might be right forProstate Cancer University of Texas Southwestern Medical Center 2
Not applicableStudy completedNCT00899912What this trial is testingChanges in DNA After Radiation Therapy in Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 13
Testing effectiveness (Phase 2)Looking for participantsNCT05346848What this trial is testingRandomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate CancerWho this might be right forProstate Cancer Institut Bergonié 62
Not applicableEnded earlyNCT00619515What this trial is testingStereotactic Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Case Comprehensive Cancer Center 73
Large-scale testing (Phase 3)WithdrawnNCT03488810What this trial is testingApalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate CancerWho this might be right forProstate Cancer European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00005044What this trial is testingHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 1,579
Testing effectiveness (Phase 2)UnknownNCT05285319What this trial is testingTrial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate CancerWho this might be right forProstate Cancer Cairo University 82
Testing effectiveness (Phase 2)UnknownNCT02643511What this trial is testingHemiablative Focal Brachytherapy Pilot StudyWho this might be right forProstate Cancer St George Hospital, Australia 20
Not applicableNot Yet RecruitingNCT07492381What this trial is testingA Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate CancerWho this might be right forProstate Cancer ALPFA Medical 50
Not applicableActive Not RecruitingNCT05361902What this trial is testingA First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate CancerWho this might be right forProstate Cancer Erasmus Medical Center 35
Not applicableLooking for participantsNCT07219303What this trial is testingAdaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerWho this might be right forProstate Cancer (Adenocarcinoma) Fox Chase Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT03113617What this trial is testing68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate CancerWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma Andrei Iagaru 44
Not applicableStudy completedNCT01423474What this trial is testingProstate Accurately Targeted Radiotherapy Investigation of Overall Treatment TimeWho this might be right forProstatic Neoplasms CancerCare Manitoba 152
Early research (Phase 1)Looking for participantsNCT06613100What this trial is testingEvaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerWho this might be right forProstate Cancer Amgen 40